CS logo
small CS logo
Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy

Miami, Florida, United States

About Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy


During the past decade, Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy


According to Clinical.Site data, the most researched conditions in "Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy" are "Renal Impairment" (3 trials), "Healthy Volunteer" (1 trials), "Hepatic Impairment" (1 trials) and "Severe Hepatic Impairment" (1 trials). Many other conditions were trialed in "Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy" in a lesser frequency.

Clinical Trials Intervention Types at Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy


Most popular intervention types in "Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Dacomitinib" (1 trials), "Glasdegib 100 mg single oral dose" (1 trials), "PF-06651600" (1 trials), "PF-06700841" (1 trials) and "PF-07321332/ritonavir" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy


The vast majority of trials in "Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy" are 5 trials for "All" genders.

Clinical Trials Status at Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy


Currently, there are NaN active trials in "Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Research Pharmacy, 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".